Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell IDEXX Laboratories, Inc. (IDXX) – IDEXX Laboratories, Inc. Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

IDEXX Laboratories (IDXX) trades at $567.46, up 2.49% with strong earnings momentum after beating estimates for three consecutive quarters. The stock shows bearish technical signals but maintains robust fundamentals with 24.62% net margins and 66.2% ROE. Recent institutional buying and positive analyst coverage (59% buy ratings) support the stock despite high valuation multiples (P/E 42.87).
The outlook remains positive with Q1 2026 earnings expected to continue the beat streak, though technical weakness near resistance at $568 poses near-term risk. Upside to the $719 consensus target offers 27% potential, balanced by premium valuation concerns and competitive pressures in animal health markets.
Read full analysis

Key Stats

  • Market Cap
    $45.07B
  • Sector
    Health
  • 3M Drawdown
    -16.2%
  • Enterprise Value
    $45.87B
  • Dividend Yield
    -
  • Typical Hold Time
    43 days
$567.46
52W Low: $471.9
02 May 2025
52W High: $766.68
25 Nov 2025

IDEXX Laboratories, Inc. (IDXX) is currently valued at a market capitalization of $45.07B, with an enterprise value of $45.87B. Over the past 52 weeks, IDEXX Laboratories, Inc. has traded between a low of $471.9 and a high of $766.68, highlighting its annual price range. Over the past three months, IDEXX Laboratories, Inc. has recorded a drawdown of -16.2%, reflecting recent price volatility. On average, investors hold IDEXX Laboratories, Inc. for approximately 43 days, indicating typical investor behavior on the platform.

About IDEXX Laboratories, Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.


Technical Indicators
|
|
|
Overall Summary
Bearish (11)Neutral (10)Bullish (6)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $45.07B
  • Sector
    Health
  • 3M Drawdown
    -16.2%
  • Enterprise Value
    $45.87B
  • Dividend Yield
    -
  • Typical Hold Time
    43 days
$567.46
52W Low: $471.9
02 May 2025
52W High: $766.68
25 Nov 2025

IDEXX Laboratories, Inc. (IDXX) is currently valued at a market capitalization of $45.07B, with an enterprise value of $45.87B. Over the past 52 weeks, IDEXX Laboratories, Inc. has traded between a low of $471.9 and a high of $766.68, highlighting its annual price range. Over the past three months, IDEXX Laboratories, Inc. has recorded a drawdown of -16.2%, reflecting recent price volatility. On average, investors hold IDEXX Laboratories, Inc. for approximately 43 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!